Business Description
![Herantis Pharma PLC Herantis Pharma PLC logo](https://static.gurufocus.com/logos/0C0000AOID.png?14)
Herantis Pharma PLC
ISIN : FI4000087861
Compare
Compare
Traded in other countries / regions
HRTIS.FinlandHRPMF.USA IPO Date
2018-10-04Description
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 185.37 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.12 | |||||
Interest Coverage | 7.33 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 37.4 | |||||
3-Year Book Growth Rate | -31.9 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.39 | |||||
Quick Ratio | 3.39 | |||||
Cash Ratio | 3.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.3 | |||||
Shareholder Yield % | -2.96 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | 29.88 | |||||
ROA % | 4.64 | |||||
ROIC % | 10.63 | |||||
ROCE % | 7.85 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 6.62 | |||||
Price-to-Tangible-Book | 6.75 | |||||
EV-to-EBIT | 82.38 | |||||
EV-to-EBITDA | 82.38 | |||||
EV-to-FCF | -5.35 | |||||
Price-to-Net-Current-Asset-Value | 6.75 | |||||
Price-to-Net-Cash | 7.02 | |||||
Earnings Yield (Greenblatt) % | 1.21 | |||||
FCF Yield % | -14.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HRPMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Herantis Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.119 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 3.51 - 3.51 | ||
Shares Outstanding (Mil) | 16.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Herantis Pharma PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Herantis Pharma PLC Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Herantis Pharma PLC Frequently Asked Questions
What is Herantis Pharma PLC(HRPMF)'s stock price today?
The current price of HRPMF is $3.51. The 52 week high of HRPMF is $3.51 and 52 week low is $3.51.
When is next earnings date of Herantis Pharma PLC(HRPMF)?
The next earnings date of Herantis Pharma PLC(HRPMF) is 2025-03-06 Est..
Does Herantis Pharma PLC(HRPMF) pay dividends? If so, how much?
Herantis Pharma PLC(HRPMF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |